Oxford AstraZeneca Covid-19 vaccine 70% effective on average, scientists find
#Scientists have found that #Oxford #AstraZeneca's #Covid-19 #vaccine to be 70% effective by averaging the results from two tests.
The UK began distributing the Oxford/AstraZeneca COVID-19 vaccine on Monday after becoming the first country to authorise it. India has approved the COVID-19 vaccine developed by AstraZeneca and Oxford University, paving the way for a huge immunisation campaign in the world's second most populous country. Oxford/AstraZeneca's vaccine becomes the second vaccine in the U.K. authorized for emergency use, plus the first known case of the U.K. COVID variant in the U.S. has been detected in Colorado. The AstraZeneca COVID-19 vaccine is expected to be cheaper and easier to store compared to the two vaccines that are already in use. The trial of this vaccine is currently underway in the U.S. Learn more about its progress.